| NCT ID | NCT05099432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Princess Alexandra Hospital, Brisbane, Australia |
| Condition | Colonic Polyp |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2021-11 |
| Primary Completion | 2023-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2021-11 with a primary completion date of 2023-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Colonoscopic removal of polyps is an important and well-established tool in the prevention of colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with resultant development of interval cancers, remains a problem; this most commonly stems from unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed that will allow endoscopists to consistently achieve a clear margin of resection. The investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will address this problem. This novel technique focuses on a standardised assessment of the resection margin after endoscopic polypectomy utilising available standard high-definition video endoscopes with imaging features including narrow band imaging (NBI) and magnification endoscopy.
Eligibility Criteria
Patients with colonic polyps will be considered following below criteria Inclusion Criteria: \- any polypectomy (though only a maximum of two polyps from one individual participant) Exclusion Criteria: * polyps less than 10mm which were resected under endoscopic view with a definite \> 1mm clear margin * scar site recurrence polyps * polyps with endoscopic evidence of invasion * pedunculated polyps * pseudopolyps * participants who will not be available for follow up endoscopy
Contact & Investigator
Alexander Huelsen, MD
PRINCIPAL INVESTIGATOR
Princess Alexandra Hospital
Frequently Asked Questions
Who can join the NCT05099432 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Colonic Polyp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05099432 currently recruiting?
Yes, NCT05099432 is actively recruiting participants. Contact the research team at alexander.huelsenkatz@health.qld.gov.au for enrollment information.
Where is the NCT05099432 trial being conducted?
This trial is being conducted at Woolloongabba, Australia.
Who is sponsoring the NCT05099432 clinical trial?
NCT05099432 is sponsored by Princess Alexandra Hospital, Brisbane, Australia. The principal investigator is Alexander Huelsen, MD at Princess Alexandra Hospital. The trial plans to enroll 60 participants.